Norgine is a European specialty pharmaceutical company, founded in 1906 and based in Amsterdam, best known in cancer care for bowel preparations used before colonoscopy and for in-licensed cancer medicines.
Norgine is a privately held European pharmaceutical company headquartered in Amsterdam with a history going back to 1906. It markets gastroenterology and supportive-care products, including bowel-cleansing preparations used ahead of colonoscopy and colorectal cancer screening, and licenses oncology medicines for Europe and Australia. It appears on ClinicalTrials.gov as lead sponsor of phase 3 trials in cancer settings.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Pivotal (registrational) trial, Clinical trial, Colorectal cancer.
Shares Pivotal (registrational) trial, Clinical trial, Colorectal cancer.